Response of Clarification sought from BSE Limited

SPARC/Sec/SE/2026-27/48 November 11, 2026 BSE Limited Market Operations Dept. P J Towers, Dalal street, Mumbai – 400001 Scrip Symbol – 532872 Sub: Clarification – Increase in Volume Ref: L/SURV/ONL/PV/SG/ 2026-2027 / 473 Dear Sir/Madam, With reference to above referred communication, we confirm that the Company is in compliance with the requirements of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and that all the disclosures required to be made under the said regulation have been made to the exchanges. We are not aware of any information which qualifies to be disclosed under the said regulation but have not been disclosed. We remain committed to make adequate and timely disclosures to the Stock Exchanges in compliance with the applicable regulations. We request you to kindly take the same on record. Yours sincerely, For Sun Pharma Advanced Research Company Limited Kajal Damania Company Secretary and Compliance Officer